Marius Pharmaceuticals backs FDA proposal to revise testosterone therapy warnings

Marius Pharmaceuticals backs FDA proposal to revise testosterone therapy warnings

Marius Pharmaceuticals has backed a move by the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) to update prescribing information for testosterone replacement therapies, saying the changes reflect years of accumulating scientific evidence. Announced during Men’s Health Month, the proposed revisions would remove language stating that the safety and effectiveness of testosterone therapy for age-related…